HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of a genetic variant in the angiopoietin-like protein 4 gene with cervical cancer.

AbstractBACKGROUND:
Cervical cancer is among the most aggressive gynecological tumors and is a consequence of interactions between genetic and epigenetic factors. Several genetic polymorphisms related to cervical cancer have been reported in previous clinical studies. In this study, we aimed to explore the possible relationship between polymorphisms of the ANGPTL4 gene locus and susceptibility to cervical cancer.
METHODS:
We investigated the relationship between a single nucleotide polymorphism (SNP) in the ANPGTL4 gene (rs116843064) and risk of cervical cancer in a total of 378 individuals with (n = 151), or without (n = 227) cancer. DNA was extracted, and genotyped using a Taq-Man based real time PCR.
RESULTS:
The ANPGTL4 polymorphism was found to be associated with an increased risk of developing cervical neoplasia using dominant model (OR = 12.48, CI = 4.9-31.82, p < 0.0001) and additive model (OR = 30.54, CI = 7.35-126.89, p < 0.0001).
CONCLUSION:
Our results indicate that there is a strong association between ANPGTL4 and the susceptibility for cervical cancer suggesting that it is a potential risk factor for cervical neoplasia.
AuthorsFarzad Rahmani, Malihe Hasanzadeh, Seyed Mahdi Hassanian, Majid Khazaei, Habibollah Esmaily, Seyed Ami Asef-Agah, Alireza Naghipour, Gordon A Ferns, Amir Avan
JournalPathology, research and practice (Pathol Res Pract) Vol. 216 Issue 7 Pg. 153011 (Jul 2020) ISSN: 1618-0631 [Electronic] Germany
PMID32534714 (Publication Type: Journal Article)
CopyrightCopyright © 2020. Published by Elsevier GmbH.
Chemical References
  • ANGPTL4 protein, human
  • Angiopoietin-Like Protein 4
Topics
  • Adult
  • Aged
  • Angiopoietin-Like Protein 4 (genetics)
  • Female
  • Genetic Predisposition to Disease (genetics)
  • Genotype
  • Humans
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Uterine Cervical Neoplasms (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: